
Weight-loss drugs receive updated warning due to unexpectedly high rate of concerning reactions
A recent warning has been issued regarding weight loss and diabetes medications due to an increasing number of concerning reactions reported. GLP-1 agonists, which are injectable diabetes medications, have seen a surge in usage over the past few years. Semaglutide…















